Trafalgar International (GCAN) Other Non Operating Income (2016 - 2025)
Trafalgar International (GCAN) posted Other Non Operating Income of -$57920.0 for Q1 2025, down 5792100.0% on a QoQ basis from $1.0 in Q4 2021.
Powered by 
Analysis
Trafalgar International (GCAN) Other Non Operating Income (2016 - 2025) Analysis & Trends
Trafalgar International has reported Other Non Operating Income for 7 years, with the latest figure at -$57920.0 in Q1 2025.
- On a quarterly basis, Other Non Operating Income changed N/A year-over-year to -$57920.0 in Q1 2025; TTM through Mar 2025 was $290199.0, a N/A change from a year earlier, with the FY2025 full-year figure at $80776.0, changed N/A from the prior year.
- Other Non Operating Income was -$57920.0 for Q1 2025 at Trafalgar International, down from $1.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $400834.0 in Q2 2021, with the low at -$57920.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -57,920.00 |
| Dec 31, 2021 | 1.00 |
| Sep 30, 2021 | -52,716.00 |
| Jun 30, 2021 | 400,834.00 |
| Mar 31, 2021 | -22,210.00 |
| Dec 31, 2020 | -2.20 Mn |
| Sep 30, 2020 | -467,555.00 |
| Jun 30, 2020 | 1.25 Mn |
| Mar 31, 2020 | -551,941.00 |
| Dec 31, 2019 | -514,576.00 |
| Sep 30, 2019 | 24,035.00 |
| Jun 30, 2019 | 82,065.00 |
| Mar 31, 2019 | 88,451.00 |
| Dec 31, 2018 | 202,357.00 |
| Sep 30, 2018 | -212,165.00 |
| Jun 30, 2018 | 31,847.00 |
| Mar 31, 2018 | 5,903.00 |
| Dec 31, 2017 | 9,902.00 |
| Sep 30, 2017 | 41,151.00 |
| Jun 30, 2017 | 132,850.00 |